Skip to main content
Cancer Explained
Donate
Beginner 6 min readSource verified

When Imaging, Biopsy, and Blood Tests Seem to Disagree

Why a scan, a biopsy and a blood test can point in different directions, how a tumour board resolves it, and why the biopsy is usually decisive.

NCI source

National Cancer Institute

A woman checks in at a Women's Imaging Center desk with pink ribbon signage
Treatment Care Scene 19

Key fact

Each test answers a different question. Imaging shows shape and size, biopsy shows what the cells actually are, and blood tests measure substances that can rise for many reasons.

The short answer

Scans, biopsies and blood tests measure different things, so they can appear to disagree. Tissue from a biopsy is usually the deciding evidence, and a tumour board weighs the whole picture.

  • Each test answers a different question. Imaging shows shape and size, biopsy shows what the cells actually are, and blood tests measure substances that can rise for many reasons.

  • Tissue is usually decisive. Imaging can suggest cancer, but a diagnosis is generally confirmed by a pathologist looking at cells.

  • Tumour markers alone cannot diagnose cancer. Noncancerous conditions raise them, some people with cancer have normal levels, and some healthy people have raised levels.

  • A negative biopsy from an area that looks suspicious on imaging may mean the needle missed the target rather than that there is no cancer.

Choose how you want to understand this

The full explanation.

Three Tests, Three Different Questions

When your scan, your biopsy and your bloods appear to say different things, it can feel as though the system has lost track of your case. Usually the tests have not contradicted each other at all. They were never answering the same question.

  • Imaging answers what shape is there and how big is it? It sees density, structure and metabolic activity, not identity.
  • Biopsy answers what are these cells? It looks directly at tissue and is the only test that can name a cancer with confidence.
  • Blood tests answer how much of a particular substance is circulating? That substance may come from cancer, or from something else entirely.

Asking three tools with three different jobs to agree exactly is asking more of them than they were designed to give.

Why Each One Can Mislead

Imaging cannot distinguish cancer from inflammation, infection, scar or benign growth with certainty. Enlarged lymph nodes are frequently reactive. PET highlights metabolic activity, which infection and healing tissue also produce. Very small deposits are invisible altogether.

Biopsy is limited by where the needle went. A core taken a few millimetres from the abnormal area returns normal tissue, and that result is a true description of what was sampled and a false reassurance about the lesion. Interpretation also involves judgement, and some distinctions are genuinely difficult even for experienced pathologists.

Blood tests are the least specific. As NCI explains, noncancerous conditions can raise tumour marker levels, not everyone with a given cancer has a raised marker, and marker measurements are usually combined with biopsy and imaging rather than used alone. A single abnormal value is a prompt to look further, not a diagnosis.

Why the Biopsy Usually Wins

Tissue carries the most information. A pathologist can see cell architecture, run immunohistochemical stains that identify the tissue of origin, and perform molecular testing that determines which treatments will work. Imaging and blood tests can suggest; tissue identifies.

But this only holds when the biopsy actually sampled the lesion in question. That caveat is why a negative biopsy from a lesion that looks convincingly malignant on imaging is treated as an unresolved question rather than an all-clear. Radiologists and pathologists specifically review such cases together, and a repeat biopsy, a larger sample, or surgical removal is often recommended.

How a Tumour Board Resolves It

Most cancer centres run multidisciplinary tumour boards: scheduled meetings where a radiologist, a pathologist, a surgeon, a medical oncologist, a radiation oncologist and often nursing and palliative care colleagues review a case together.

In a discordant case, the discussion typically works through:

  1. Does the tissue match the picture? The pathologist and radiologist compare what was sampled with where the abnormality actually sits.
  2. Was the sample adequate? A small or crushed sample may not support a firm conclusion.
  3. Does the biology make sense? A diagnosis that does not fit the pattern of spread or the clinical course prompts a re-look.
  4. What single test would resolve this? Often a repeat biopsy, a different imaging method, a second pathology opinion, or simply repeating the scan after a defined interval.

Second-opinion pathology review is a routine part of this at many centres and sometimes changes a diagnosis or a subtype. Requesting it is not an accusation.

Time Is Sometimes the Test

When no result is urgent and the tests conflict, repeating a scan after an interval can be more informative than adding another test now. Something that grows behaves differently from something that does not, and stability over months is itself evidence. If your team suggests waiting, it is fair to ask what they expect to see and what would change the plan.

What You Can Do

Ask which result they are weighting most heavily and why. Ask whether your case has gone to a tumour board and what was concluded. Ask whether a repeat biopsy or a second pathology read would change anything. Keep copies of your reports so you can see the sequence yourself.

Living inside an unresolved result is genuinely hard. Naming what is still unknown, and what would settle it, usually makes the wait more bearable than trying to force a conclusion the evidence does not yet support.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

Two clinicians in scrubs position a patient lying on the couch of a linear accelerator, one steadying the head support and the other resting a hand on the patient’s torso.

Common questions

My scan says something suspicious but my biopsy was negative. Which do I believe?

Neither on its own. This combination is described as discordant, and it is taken seriously rather than dismissed. The usual interpretation is that the needle may not have hit the abnormality, which is why radiologists and pathologists review such cases together and often recommend repeating the biopsy, sampling a different part of the lesion, or removing it surgically. A negative biopsy is only as reliable as the accuracy of the sampling.

My tumour marker went up but my scans are stable. Should I be worried?

A single rise is generally not acted on. Markers fluctuate, and noncancerous conditions can raise them. As NCI notes, marker results are usually combined with other tests rather than used alone. Most teams will repeat the test after an interval and look at the trend. A steady climb across several measurements carries more weight than one abnormal value.

What is a tumour board and can I ask for one?

It is a scheduled meeting where specialists from different disciplines review a case together: radiology, pathology, surgery, medical oncology, radiation oncology and often nursing and palliative care. Many cancer centres review every new case routinely. You can ask whether yours has been discussed and what the meeting concluded.

Why would two pathologists read the same slide differently?

Pathology involves expert interpretation, not just measurement, and certain distinctions are genuinely difficult — rare tumour types, lymphoma subtyping, borderline grading, and telling reactive changes from cancer. Second-opinion review at a specialist centre sometimes changes a diagnosis or a subtype, which is why it is routine practice at many cancer centres rather than a sign of doubt about anyone's competence.

Is it reasonable to ask for more time before deciding?

Often yes, and sometimes waiting is the plan. When results conflict and none of them is urgent, repeating a scan after a defined interval can resolve the question better than another test now, because change over time is itself evidence. Ask your team directly whether a short delay carries any risk in your situation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the federal sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Written by: Cancer Explained Editorial TeamSources last checked: 2026-07-30Last updated: 2026-07-30Next planned review: 2027-07-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source verified This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Still have questions?

Educational answers, plain language

Ask Cancer Explained

Doctor Visit Prep Tool

Get a personalized list of questions to ask about this topic.

Start the guide

Related learning map

How this explanation connects to 10 other things you can explore — related topics, terms, questions, practice, and its NCI source.

When Imaging, Biopsy, and Blood Tests Seem to Disagree